Mallinckrodt Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 6.09, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Mallinckrodt Plc in Jun 30 2026 quarter, has decreased to 60 days, compared to 66 days, in the Jun 27 2025 quarter.

If we take a look into Healthcare sector 450 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2900 to 3082.

What is Receivable Turnover Ratio?
What is Mallinckrodt Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MNKKQ Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Jun 27 2025) II. Quarter	(Dec 27 2024) IV. Quarter	(Jun 16 2022) II. Quarter	(Apr 01 2022) I. Quarter
Y / Y Receivable Change	-23.43 %	-4.86 %	-73.03 %	-23.67 %	-18.5 %
Y / Y Revenue Change	5.36 %	-18.77 %	-2.98 %	-29.78 %	-12.03 %
Receivable Turnover Ratio (TTM)	6.09	5.55	5.79	4.7	4.76
MNKKQ's Total Ranking	# 3082	# 2900	#	#	#
Accounts Receivable average collection period days	60	66	63	78	77
Seq. Receivable Change	-18.14 %	238.58 %	-66.71 %	-17.01 %	1.71 %
Seq. Revenue Change	6.62 %	-1.42 %	28.25 %	-21.84 %	-17.8 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 142
Healthcare Sector	# 451
Overall Market	# 3082

Receivable Turnover Ratio Statistics
High	Average	Low
1	0.3	0.17
(Dec 27 2013)		(Sep 28 2018)

MNKKQ Company Profile • Back to MNKKQ Efficiency Comparisons • Compare MNKKQ Receivables Turnover Ratio to its Competitors

Financial Statements
Mallinckrodt Plc's Accounts Receivable	$ 336 Millions	Visit MNKKQ's Balance sheet
Mallinckrodt Plc's Sales TTM	$ 1,878 Millions	Visit MNKKQ's Income Statement
Sources of MNKKQ's Revenues		Visit MNKKQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MNKKQ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MNKKQ's Growth Rates	MNKKQ's Roa	MNKKQ's Inventory Turnover Ratio	MNKKQ's Dividend Comparisons
MNKKQ's Profitability Ratios	MNKKQ's Roi	MNKKQ's Asset Turnover Ratio	MNKKQ's Dividend Growth
MNKKQ's Valuation Ratios	MNKKQ's Roe	MNKKQ's Financial Strength Ratios	MNKKQ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Vaxart Inc	15.09	$ 243.064 Millions	$ 16.108 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
Skinhealth Systems Inc	14.42	$ 289.224 Millions	$ 20.051 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
10x Genomics Inc	13.90	$ 616.566 Millions	$ 44.342 Millions
Amneal Pharmaceuticals Inc	13.90	$ 3,117.474 Millions	$ 224.342 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Corcept Therapeutics Inc	13.54	$ 830.813 Millions	$ 61.352 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Nrc Health	12.72	$ 139.996 Millions	$ 11.004 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.98	$ 8.855 Millions	$ 0.739 Millions
Teladoc Health Inc	11.88	$ 2,489.480 Millions	$ 209.556 Millions
Premier Air Charter Holdings Inc	11.72	$ 31.562 Millions	$ 2.692 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions

Date modified: 2026-09-18T17:35:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.